These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 21029497)

  • 21. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inflammatory bowel disease and pregnancy].
    Duvnjak M; Lerotić I; Tomasić V; Pavić T; Virović L
    Lijec Vjesn; 2006; 128(1-2):48-55. PubMed ID: 16640228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study.
    Farraye FA; Waye JD; Moscandrew M; Heeren TC; Odze RD
    Gastrointest Endosc; 2007 Sep; 66(3):519-29. PubMed ID: 17640638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy and inflammatory bowel disease: a review of the literature.
    Sorokin JJ; Levine SM
    Obstet Gynecol; 1983 Aug; 62(2):247-52. PubMed ID: 6346173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD)].
    Raspe H; Conrad S; Muche-Borowski C
    Z Gastroenterol; 2009 Jun; 47(6):541-62. PubMed ID: 19533545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W; Wolf LM; Grotz W; Grieshaber M
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inflammatory diseases of the digestive system and pregnancy: clinical case and review of the literature].
    Restellini A
    Schweiz Rundsch Med Prax; 1989 May; 78(19):560-4. PubMed ID: 2662327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory bowel disease.
    Gurudu S; Fiocchi C; Katz JA
    Best Pract Res Clin Gastroenterol; 2002 Feb; 16(1):77-90. PubMed ID: 11977930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.
    Riis L; Vind I; Politi P; Wolters F; Vermeire S; Tsianos E; Freitas J; Mouzas I; Ruiz Ochoa V; O'Morain C; Odes S; Binder V; Moum B; Stockbrügger R; Langholz E; Munkholm P;
    Am J Gastroenterol; 2006 Jul; 101(7):1539-45. PubMed ID: 16863558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis.
    Longobardi T; Jacobs P; Bernstein CN
    Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey.
    Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE
    Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of inflammatory bowel disease].
    Jojić N
    Acta Chir Iugosl; 2000; 47(1-2):51-5. PubMed ID: 10953366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endoscopy in IBD. A Consensus Report of the IBD Working of the Austrian Association of Gastroenterology and Hepatology].
    Petritsch W; Tillinger W; Vogelsang H; Reinisch W; Knoflach P; Tilg H
    Z Gastroenterol; 2006 Nov; 44(11):1183-92. PubMed ID: 17115362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.
    Riley TR; Schoen RE; Lee RG; Rakela J
    Am J Gastroenterol; 1997 Feb; 92(2):279-82. PubMed ID: 9040206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.